XERS logo

Xeris Biopharma Holdings, Inc. (XERS) Cash From Investing

Annual CFI:

$4.88M+$10.89M(+181.33%)
December 31, 2024

Summary

  • As of today, XERS annual cash from investing is $4.88 million, with the most recent change of +$10.89 million (+181.33%) on December 31, 2024.
  • During the last 3 years, XERS annual cash from investing has fallen by -$93.08 million (-95.02%).
  • XERS annual cash from investing is now -95.02% below its all-time high of $97.96 million, reached on December 31, 2021.

Performance

XERS Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherXERScash flow metrics

Quarterly CFI:

-$279.00K-$266.00K(-2046.15%)
June 30, 2025

Summary

  • As of today, XERS quarterly cash from investing is -$279.00 thousand, with the most recent change of -$266.00 thousand (-2046.15%) on June 30, 2025.
  • Over the past year, XERS quarterly cash from investing has dropped by -$4.88 million (-106.06%).
  • XERS quarterly cash from investing is now -100.76% below its all-time high of $36.60 million, reached on December 31, 2021.

Performance

XERS Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherXERScash flow metrics

TTM CFI:

$19.64M-$4.88M(-19.91%)
June 30, 2025

Summary

  • As of today, XERS TTM cash from investing is $19.64 million, with the most recent change of -$4.88 million (-19.91%) on June 30, 2025.
  • Over the past year, XERS TTM cash from investing has increased by +$5.16 million (+35.66%).
  • XERS TTM cash from investing is now -79.95% below its all-time high of $97.96 million, reached on December 31, 2021.

Performance

XERS TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherXERScash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

XERS Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+181.3%-106.1%+35.7%
3Y3 Years-95.0%-102.3%-73.3%
5Y5 Years+304.9%-101.6%+144.9%

XERS Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-95.0%+181.3%-101.9%+99.4%-68.3%+199.9%
5Y5-Year-95.0%+117.8%-100.8%+99.5%-80.0%+144.9%
All-TimeAll-Time-95.0%+107.2%-100.8%+99.5%-80.0%+122.7%

XERS Cash From Investing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$279.00K(-2046.2%)
$19.64M(-19.9%)
Mar 2025
-
-$13.00K(-100.1%)
$24.52M(+402.2%)
Dec 2024
$4.88M(+181.3%)
$10.02M(+1.0%)
$4.88M(-49.8%)
Sep 2024
-
$9.91M(+115.4%)
$9.73M(-32.8%)
Jun 2024
-
$4.60M(+123.4%)
$14.48M(-21.0%)
Mar 2024
-
-$19.65M(-232.2%)
$18.32M(+405.2%)
Dec 2023
-$6.00M(-117.4%)
$14.87M(+1.5%)
-$6.00M(+48.7%)
Sep 2023
-
$14.65M(+73.4%)
-$11.70M(+40.4%)
Jun 2023
-
$8.45M(+119.2%)
-$19.65M(-21.0%)
Mar 2023
-
-$43.98M(-579.7%)
-$16.23M(-147.1%)
Dec 2022
$34.46M(-64.8%)
$9.17M(+36.7%)
$34.46M(-44.3%)
Sep 2022
-
$6.71M(-43.5%)
$61.90M(-16.0%)
Jun 2022
-
$11.87M(+76.7%)
$73.69M(-6.0%)
Mar 2022
-
$6.72M(-81.7%)
$78.38M(-20.0%)
Dec 2021
$97.96M
$36.60M(+97.8%)
$97.96M(+42.8%)
Sep 2021
-
$18.50M(+11.8%)
$68.61M(+749.2%)
Jun 2021
-
$16.56M(-37.1%)
-$10.57M(-8.1%)
DateAnnualQuarterlyTTM
Mar 2021
-
$26.30M(+262.8%)
-$9.78M(+64.3%)
Dec 2020
-$27.41M(-1050.0%)
$7.25M(+111.9%)
-$27.41M(+37.3%)
Sep 2020
-
-$60.67M(-449.8%)
-$43.70M(-401.7%)
Jun 2020
-
$17.34M(+99.9%)
$14.48M(-42.1%)
Mar 2020
-
$8.68M(+196.0%)
$25.02M(+1149.9%)
Dec 2019
-$2.38M(+96.5%)
-$9.04M(-262.2%)
-$2.38M(+53.0%)
Sep 2019
-
-$2.50M(-109.0%)
-$5.07M(+91.4%)
Jun 2019
-
$27.88M(+248.9%)
-$58.62M(+32.4%)
Mar 2019
-
-$18.73M(-59.7%)
-$86.65M(-26.9%)
Dec 2018
-$68.26M(-9651.6%)
-$11.72M(+79.1%)
-$68.26M(-20.2%)
Sep 2018
-
-$56.05M(>-9900.0%)
-$56.77M(-7469.9%)
Jun 2018
-
-$156.00K(+53.2%)
-$750.00K(-26.3%)
Mar 2018
-
-$333.00K(-41.1%)
-$594.00K(+1.5%)
Dec 2017
-$700.00K(-1900.0%)
-$236.00K(-844.0%)
-$603.00K(-64.3%)
Sep 2017
-
-$25.00K(+92.7%)
-$367.00K(-7.3%)
Mar 2017
-
-$342.00K
-$342.00K
Dec 2016
-$35.00K
-
-

FAQ

  • What is Xeris Biopharma Holdings, Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for Xeris Biopharma Holdings, Inc.?
  • What is Xeris Biopharma Holdings, Inc. annual cash from investing year-on-year change?
  • What is Xeris Biopharma Holdings, Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Xeris Biopharma Holdings, Inc.?
  • What is Xeris Biopharma Holdings, Inc. quarterly cash from investing year-on-year change?
  • What is Xeris Biopharma Holdings, Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for Xeris Biopharma Holdings, Inc.?
  • What is Xeris Biopharma Holdings, Inc. TTM cash from investing year-on-year change?

What is Xeris Biopharma Holdings, Inc. annual cash from investing?

The current annual cash from investing of XERS is $4.88M

What is the all-time high annual cash from investing for Xeris Biopharma Holdings, Inc.?

Xeris Biopharma Holdings, Inc. all-time high annual cash from investing is $97.96M

What is Xeris Biopharma Holdings, Inc. annual cash from investing year-on-year change?

Over the past year, XERS annual cash from investing has changed by +$10.89M (+181.33%)

What is Xeris Biopharma Holdings, Inc. quarterly cash from investing?

The current quarterly cash from investing of XERS is -$279.00K

What is the all-time high quarterly cash from investing for Xeris Biopharma Holdings, Inc.?

Xeris Biopharma Holdings, Inc. all-time high quarterly cash from investing is $36.60M

What is Xeris Biopharma Holdings, Inc. quarterly cash from investing year-on-year change?

Over the past year, XERS quarterly cash from investing has changed by -$4.88M (-106.06%)

What is Xeris Biopharma Holdings, Inc. TTM cash from investing?

The current TTM cash from investing of XERS is $19.64M

What is the all-time high TTM cash from investing for Xeris Biopharma Holdings, Inc.?

Xeris Biopharma Holdings, Inc. all-time high TTM cash from investing is $97.96M

What is Xeris Biopharma Holdings, Inc. TTM cash from investing year-on-year change?

Over the past year, XERS TTM cash from investing has changed by +$5.16M (+35.66%)
On this page